Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

@inproceedings{Pullman2017EfficacyAS,
  title={Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study},
  author={J. Barrett Pullman and Jănis Gardovskis and Bob Farley and Eugene F Sun and Megan Quintas and Laura E. Lawrence and Rennan Ling and Sue Cammarata},
  booktitle={The Journal of antimicrobial chemotherapy},
  year={2017}
}
Background Delafloxacin is an investigational anionic fluoroquinolone in development for oral or intravenous administration for the treatment of infections caused by Gram-positive (including MRSA), Gram-negative, atypical and anaerobic organisms. Objectives To establish the non-inferiority of delafloxacin compared with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections and to compare the safety of the two antimicrobials. Patients and methods A… CONTINUE READING
4
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin

  • European Journal of Drug Metabolism and Pharmacokinetics
  • 2018
VIEW 8 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
VIEW 4 EXCERPTS
CITES RESULTS, METHODS & BACKGROUND
HIGHLY INFLUENCED

Current Treatment Options for Acute Skin and Skin-structure Infections

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019

New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship

Shio-Shin Jean, Ian M. Gould, Wen-Sen Lee, Po-Ren Hsueh, International Society of Antimicrobial Chemotherapy
  • Drugs
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2016

A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections.

  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
  • 2015

Assessment of phototoxicity potential of delafloxacin in healthy male and female subjects: a Phase 1 study

J Ferguson, L Lawrence, S Paulson
  • Abstracts of the Fifty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy,
  • 2015

Similar Papers

Loading similar papers…